Effect Of Certolizumab Pegol Over 48 Weeks On Signs and Symptoms In Patients With Psoriatic Arthritis With and Without Prior Tumor Necrosis Factor Inhibitor Exposure
Author(s):
Mease, P.J.; Fleischmann, R.M.; Wollenhaupt, J.; Deodhar, A.; Gladman, D.; Stach, C.; Hoepken, B.; Peterson, L.; Heijde, D. van der
Published
2013
Publication type
Article / Letter to editor
Date issued
2013-10-31
Language
English
Is part of
Arthritis and Rheumatism (2013), Vol. 65, p. S132-S133
